BenzingaAugust 13, 2026 at 12:53 PM NY2 Months Ago
UBS Maintains Neutral on Xylem, Raises Price Target to $138
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $135 to $138.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
